Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis on organoids derived from metastatic tumor patients

ABSTRACT: RNA-seq analysis on organoids derived from metastatic tumor patients

PROVIDER: PRJNA1103724 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28779972_1.fastq.gz	Fastqsanger.gz
	SRR28779972_2.fastq.gz	Fastqsanger.gz
	SRR28779973_1.fastq.gz	Fastqsanger.gz
	SRR28779973_2.fastq.gz	Fastqsanger.gz
	SRR28779974_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

RNA-seq analysis on organoids derived from metastatic tumor patients

Project description:To evaluate the efficiency of apatinib on vascularized patient-derived tumor organoids (PDTOs)-on-a-chip derived from patients with metastatic tumors, we conducted RNA-seq analysis on organoids derived from patients whom had metastatic tumors. Specifically, we extracted RNA for sequencing from tumor cells of organoids either cultured alone or co-cultured with MVs with or without apatinib treatment

2024-04-27 | GSE264645 | GEO

Modeling Tumor Development and Metastasis using Paired Organoids Derived from Patients with Colorectal Cancer Liver Metastases

Project description:Tumor metastasis accounts for the majority of cancer-related deaths; it is therefore important to develop preclinical models that faithfully recapitulate disease progression. Here, we generated paired organoids derived from primary tumors and matched liver metastases in the same colorectal cancer patients (CRC). Despite the fact that paired organoids exhibit comparable gene expression and cell morphology. organoids from metastatic lesions demonstrate more aggressive phenotypes, tumorigenesis, and metastatic capacity than those from primary lesions. Transcriptional analyses of the paired organoids reveal signature genes and pathways altered during the progression of CRC. including SOX2, altered during the progression of CRC. Further study shows that inducible knockdown of SOX2 attenuated invasion, proliferation, and liver metastasis outgrowth. Taken together, we use patient-derived organoids to model cancer metastasis. Our data propose that SOX2 is not only a critical biomarker for the development and metastasis of CRC, but also a potent target for the disease treatment.

2020-10-05 | GSE148918 | GEO

Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis

Project description:Accumulating evidence indicates that patient- derived organoids (PDOs) can predict drug responses in the clinic. Metastasis is the main cause of death in colorectal cancer patients, and the treatment of patients with liver metastasis remains poor. Tumor heterogeneity is the cause of treatment failure. In this study, we aim the investigate the consistency of drug sensitivity for the matched primary and metastatic tumor in patients with liver metastasis.

| 2400343 | ecrin-mdr-crc

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study

Project description:Using patient derived lung cancer organoids to predict clinical response and find theraputic mechanisms

2022-09-26 | PXD037076 |

Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq

Project description:We report the generation and characterization of tumor organoids and PDOX derived from needle biopsies of metastatic lesions from neuroendocrine prostate cancer patients.

2018-06-22 | GSE112786 | GEO

Human patient tumor-derived organoid characterization from bladder cancer patients that did not respond to chemotherapy

Project description:A total of 3 independently derived organoids were compared to patient tumor samples and patient normal samples to determine if the tumor-derived organoids represent the genomic landscape of the tumor from which they were derived.

2023-01-02 | E-MTAB-10353 | biostudies-arrayexpress

Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

Project description:Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

| PRJNA1151740 | ENA

Expression Analysis of Mouse Tumor and Metastatic Pancreatic Ductal Adenocarcinoma Organoids

Project description:Expression Analysis of Mouse Tumor and Metastatic Pancreatic Ductal Adenocarcinoma Organoids

| PRJNA597074 | ENA

Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers.

Project description:Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers.

| PRJNA427119 | ENA

Organoids derived from pancreatic adenocarcinoma patients share morphological and genetic features with the primary tumor

Project description:Organoids derived from pancreatic adenocarcinoma patients share morphological and genetic features with the primary tumor